Cargando…
Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells
Centrosome aberrations (CA) and abnormal mitoses are considered beacons of malignancy. Cancer cell doubling times in patient tumors are longer than in cultures, but differences in CA between tumors and cultured cells are uncharacterized. We compare mitoses and CA in patient tumors, xenografts, and t...
Autores principales: | Mittal, Karuna, Choi, Da Hoon, Ogden, Angela, Donthamsetty, Shashi, Melton, Brian D., Gupta, Meenakshi. V., Pannu, Vaishali, Cantuaria, Guilherme, Varambally, Sooryanarayana, Reid, Michelle D., Jonsdottir, Kristin, Janssen, Emiel A. M., Aleskandarany, Mohammad A., Ellis, Ian O., Rakha, Emad A., Rida, Padmashree C. G., Aneja, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341055/ https://www.ncbi.nlm.nih.gov/pubmed/28272508 http://dx.doi.org/10.1038/srep43984 |
Ejemplares similares
-
KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
por: Pawar, Shrikant, et al.
Publicado: (2014) -
Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015) -
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
por: Pannu, Vaishali, et al.
Publicado: (2015) -
Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
por: Ogden, A, et al.
Publicado: (2014) -
Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
por: Ogden, Angela, et al.
Publicado: (2017)